XANAX retard cpr ret 2 mg 30 pce
7680528660578
CH-52866
N05BA12
01.04.1.
Reimbursement limitations:
120PISL
Prescription limitée au maximum à 120 points. Iniectabilia sine limitatione
1 / 3
google
Details
- Product number
- 5286603
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- alprazolamum 2 mg, lactosum monohydricum 221.7 mg, hypromellosum, magnesii stearas, silica colloidalis anhydrica, E 132 pro compresso.
Articles (1)
Xanax retard 2 mg, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
221.7 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FIMDK |
Reimbursement information
Public price
CHF 28.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1997
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 52866
- Drug name
- Xanax retard, Retardtabletten
- Galenic form
- RETT
- ATC Code
- N05BA12
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 19/06/1995
- Authorization expiration date
- 31/12/9999
- IT number
- 01.04.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XANAX retard cpr ret 2 mg 30 pce
- Description (DE)
- XANAX retard Ret Tabl 2 mg 30 Stk
- Market launch
- 19/06/1995
- Narcotic (BTM)
- B